Compare Stocks

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BNE Blue Horizon BNE ETF	$22.94 -0.3%	$22.27	$19.53 ▼ $27.62	$4.59M	1.32	746 shs	1,330 shs
GXE Gear Energy	C$0.78	C$0.67	C$0.60 ▼ C$1.04	C$205.44M	3.73	424,566 shs	1.07 million shs
OBE Obsidian Energy	$7.91 -1.2%	$0.17	$0.15 ▼ $2.70	$606.78M	1.56	435,962 shs	238,107 shs
PHAR Pharming Group	$9.33 -1.8%	$10.60	$9.27 ▼ $16.71	$626.14M	0.2	2,484 shs	744 shs

7 Stocks to Buy And Hold Forever

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BNE Blue Horizon BNE ETF	-0.30%	+3.94%	+1.59%	+8.72%	-6.21%
GXE Gear Energy	+3.31%	+9.86%	+13.04%	+21.88%	-22.77%
OBE Obsidian Energy	-1.31%	-3.53%	-5.14%	+20.52%	+26.88%
PHAR Pharming Group	-1.25%	-9.09%	-10.88%	-20.83%	-22.95%

He Is Giving Away Bitcoin (Ad)

And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.

>> Register right here

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
BNE Blue Horizon BNE ETF	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
GXE Gear Energy	3.4532 of 5 stars	3.3	0.0	1.7	0.0	3.2	1.7	1.9
OBE Obsidian Energy	1.8249 of 5 stars	3.5	0.0	0.0	0.0	0.0	0.0	2.5
PHAR Pharming Group	2.3324 of 5 stars	3.5	5.0	0.0	0.0	1.8	0.0	0.6

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BNE Blue Horizon BNE ETF	0.00	N/A	$23.46	2.28% Upside
GXE Gear Energy	2.50	Moderate Buy	C$1.00	28.21% Upside
OBE Obsidian Energy	3.00	Buy	$15.25	92.79% Upside
PHAR Pharming Group	3.00	Buy	$37.00	296.57% Upside

Current Analyst Ratings

Latest GXE, PHAR, PTAL, OBE, and BNE Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/9/2024	OBE Obsidian Energy	BMO Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$16.50
3/14/2024	PHAR Pharming Group	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$37.00

(Data available from 5/9/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BNE Blue Horizon BNE ETF	N/A	N/A	N/A	N/A	N/A	N/A
GXE Gear Energy	C$131.16M	1.57	C$0.00 per share	540.00	C$0.91 per share	0.86
OBE Obsidian Energy	$533.77M	1.14	$3.02 per share	2.62	$15.69 per share	0.50
PHAR Pharming Group	$245.32M	2.55	$0.09 per share	102.60	$3.26 per share	2.86

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BNE Blue Horizon BNE ETF	N/A	N/A	13.74	∞	N/A	N/A	N/A	N/A	N/A
GXE Gear Energy	C$9.18M	C$0.03	26.00	∞	N/A	7.00%	3.81%	4.13%	7/24/2024 (Estimated)
OBE Obsidian Energy	$80.01M	$0.80	9.89	5.82	N/A	12.45%	5.45%	3.96%	N/A
PHAR Pharming Group	-$10.55M	-$0.14	N/A	N/A	N/A	-4.13%	-4.53%	-2.14%	8/1/2024 (Estimated)

Latest GXE, PHAR, PTAL, OBE, and BNE Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
3/14/2024	Q4 2023	PHAR Pharming Group	$0.05	-$0.03	-$0.08	-$0.02	$71.83 million	$81.20 million
2/22/2024	Q4 2023	OBE Obsidian Energy	N/A	$0.31	+$0.31	$0.31	N/A	$127.31 million
2/21/2024	Q4 2023	GXE Gear Energy	C$0.02	-C$0.03	-C$0.05	-C$0.03	N/A	C$37.52 million

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
BNE Blue Horizon BNE ETF	$0.06	0.26%	N/A	N/A	N/A
GXE Gear Energy	C$0.06	7.69%	N/A	200.00%	N/A
OBE Obsidian Energy	N/A	N/A	N/A	N/A	N/A
PHAR Pharming Group	N/A	N/A	N/A	N/A	N/A

Latest GXE, PHAR, PTAL, OBE, and BNE Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/14/2024	GXE Gear Energy	Monthly	C$0.01	8.45%	5/14/2024	5/31/2024	5/31/2024
4/1/2024	GXE Gear Energy	Monthly	C$0.01	9.09%	4/12/2024	4/15/2024	4/30/2024
3/4/2024	GXE Gear Energy	Monthly	C$0.01	9.09%	3/14/2024	3/15/2024	3/29/2024
2/14/2024	GXE Gear Energy	Monthly	C$0.01	9.23%	2/14/2024	2/29/2024	2/29/2024

(Data available from 1/1/2013 forward)

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BNE Blue Horizon BNE ETF	N/A	N/A	N/A
GXE Gear Energy	9.40	1.10	0.56
OBE Obsidian Energy	0.17	0.45	0.45
PHAR Pharming Group	0.62	4.06	3.33

Ownership

Institutional Ownership

Company	Institutional Ownership
BNE Blue Horizon BNE ETF	N/A
GXE Gear Energy	2.43%
OBE Obsidian Energy	13.51%
PHAR Pharming Group	0.03%

Insider Ownership

Company	Insider Ownership
BNE Blue Horizon BNE ETF	N/A
GXE Gear Energy	7.07%
OBE Obsidian Energy	N/A
PHAR Pharming Group	2.07%

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
BNE Blue Horizon BNE ETF	N/A	200,000	N/A	Not Optionable
GXE Gear Energy	30	263.38 million	N/A	Not Optionable
OBE Obsidian Energy	N/A	76.71 million	N/A	Optionable
PHAR Pharming Group	382	67.11 million	65.72 million	Not Optionable

GXE, PHAR, PTAL, OBE, and BNE Headlines

Source	Headline
	Pharming Group N.V.: Pharming Group reports first quarter 2024 financial results and provides business update finanznachrichten.de - May 8 at 3:51 AM
	What Wall Street expects from Pharming Group NV's earnings markets.businessinsider.com - May 7 at 5:47 PM
	Pharming Group (NASDAQ:PHAR) Shares Gap Down to $10.00 marketbeat.com - May 6 at 6:30 PM
	Pharming Group (PHAR) Scheduled to Post Quarterly Earnings on Wednesday americanbankingnews.com - May 6 at 6:50 AM
	Pharming Group (NASDAQ:PHAR) Sees Unusually-High Trading Volume marketbeat.com - May 2 at 2:26 PM
	Pharming Group (PHAR) to Release Quarterly Earnings on Wednesday marketbeat.com - May 1 at 7:24 AM
	Pharming Group (NASDAQ:PHAR) Shares Gap Down to $9.91 marketbeat.com - April 30 at 5:34 PM
	Pharming Group (NASDAQ:PHAR) Trading Down 8.8% marketbeat.com - April 26 at 5:57 PM
	Pharming to be honored as Industry Innovator at National Organization for Rare Disorders (NORD®) 2024 Rare Impact Awards finance.yahoo.com - April 24 at 2:17 AM
	Pharming Group to report first quarter 2024 financial results on May 8 finance.yahoo.com - April 24 at 2:17 AM
	Pharming Group (PHAR) Surges 7.2%: Is This an Indication of Further Gains? zacks.com - April 22 at 6:31 AM
	Pharming Group N.V.: Pharming Group announces the repurchase of outstanding €125 million convertible bonds due 2025 finanznachrichten.de - April 19 at 4:05 PM
	Pharming Group (NASDAQ:PHAR) Sees Strong Trading Volume marketbeat.com - April 19 at 1:37 PM
	Pharming Group N.V.: Pharming Group announces the placement of €100 million convertible bonds due 2029 finanznachrichten.de - April 18 at 6:18 PM
	Pharming Group announces the launch of an offering of approximately €100 million convertible bonds due 2029 and the concurrent repurchase of the outstanding €125 million convertible bonds due 2025 finance.yahoo.com - April 18 at 8:17 AM
	Pharming Group (NASDAQ:PHAR) Stock Price Down 6.8% marketbeat.com - April 15 at 1:55 PM
	Pharming Group (NASDAQ:PHAR) Shares Down 5% marketbeat.com - April 9 at 3:19 PM
	Enrollment completed for trial of drug to treat children with rare primary immunodeficiency outsourcing-pharma.com - April 8 at 8:50 AM
	Pharming announces completion of enrollment in pediatric clinical trial of leniolisib finance.yahoo.com - April 8 at 1:34 AM
	Pharming Group announces the filing of its 2023 Annual Report and Form 20-F finance.yahoo.com - April 4 at 1:14 AM
	Uber to pay $178 million in Australia taxi class action settlement msn.com - March 18 at 3:45 AM
	Pharming reports Q4 results msn.com - March 15 at 7:46 PM
	Pharming Group N.V. 2023 Q4 - Results - Earnings Call Presentation seekingalpha.com - March 14 at 9:06 AM
	Pharming Group N.V.: Pharming Group to report fourth quarter and full year 2023 financial results on March 14 finanznachrichten.de - February 29 at 6:26 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Stocks Leading the U.S. Agriculture Comeback
April 26, 2024 10:10 AM
View 3 Stocks Leading the U.S. Agriculture Comeback
How to Use Put Debit Spreads to Profit From Falling Stocks
April 26, 2024 9:30 AM
View How to Use Put Debit Spreads to Profit From Falling Stocks
Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
April 26, 2024 3:21 AM
View Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
Novo Nordisk Arms Wegovy to Be a Triple Threat
April 15, 2024 7:30 AM
View Novo Nordisk Arms Wegovy to Be a Triple Threat
3 A.I. Stocks to Watch Out For Not Named NVIDIA
April 23, 2024 7:00 AM
View 3 A.I. Stocks to Watch Out For Not Named NVIDIA

All Headlines

Company Descriptions

Blue Horizon BNE ETF

NYSEARCA:BNE

The Blue Horizon BNE ETF (BNE) is an exchange-traded fund that is based on the Blue Horizon New Energy Economy 100 index. The fund tracks an equal-weighted index of global stocks that are perceived to benefit from a New Energy Economy. BNE was launched on Dec 8, 2020 and is managed by Blue Horizon.

Gear Energy

TSE:GXE

Gear Energy Ltd., an exploration and production company, engages in the acquiring, developing, and holding of interests in petroleum and natural gas properties and assets in Canada. The company's oil properties are located in Central Alberta, West Central Saskatchewan, and Southeast Saskatchewan. Gear Energy Ltd. is headquartered in Calgary, Canada.

Obsidian Energy

NYSE:OBE

Obsidian Energy Ltd. explores for, develops, and produces oil and natural gas in western Canada. It holds interests in the Alberta Viking, Cardium, Deep Basin, and Peace River areas. The company was formerly known as Penn West Petroleum Ltd. and changed its name to Obsidian Energy Ltd. in June 2017. Obsidian Energy Ltd. was founded in 1979 and is headquartered in Calgary, Canada.

Pharming Group

NASDAQ:PHAR

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial